Zavzpret to treat migraine
Drug Name: Zavzpret Indications: To treat migraine. Active Ingredient: Zavegepant Company: Pfizer Labs Approval Date: 3/9/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216386s000lbl.pdf
Drug Name: Zavzpret Indications: To treat migraine. Active Ingredient: Zavegepant Company: Pfizer Labs Approval Date: 3/9/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216386s000lbl.pdf
Drug Name: Skyclarys Indications: To treat Friedrich’s ataxia. Active Ingredient: Omaveloxolone Company: Reata Pharmaceuticals Holdings Approval Date: 2/28/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216718Orig1s000lbl.pdf
Tradename: ProQuad Proper Name: Measles, Mumps, Rubella and Varicella Virus Vaccine Live Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration…
Tradename: ALTUVIIIO Proper Name: antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl Indication: Indicated for use in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: (1) Routine prophylaxis to…
Drug Name: Filspari Indications: To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression. Active Ingredient: Sparsentan Company: Travere Therapeutics, Inc Approval Date: 2/17/2023…
Drug Name: Lamzede Indications: To treat non-central nervous system manifestations of alpha-mannosidosis. Active Ingredient: Velmanase alfa-tycv Company: Chiesi Farmaceutici Approval Date: 2/16/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761278s000lbl.pdf
Drug Name: Jesduvroq Indications: To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months. Active Ingredient: Daprodustat Company: GlaxoSmithKline Approval Date: 2/1/2023 More…
Drug Name: Jaypirca Indications: To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor Active Ingredient:…
Drug Name: Orserdu Indications: To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine…
Tradename: DENGVAXIA Proper Name: Dengue Tetravalent Vaccine, Live Indication: To include data on the immune response to Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel) when administered…